🇺🇸 FDA
Pipeline program

Resatorvid

TAK-242_301

Phase 3 small_molecule terminated

Quick answer

Resatorvid for Sepsis is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Sepsis
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials